This article has been updated to reflect that Orig3n did not acquire Interleukin's heart health test, which was previously sold. A press release announcing the acquisition inaccurately mentioned the test, according to an Orig3n spokesperson

NEW YORK (GenomeWeb) – Orig3n announced today that it has acquired Interleukin Genetics' CLIA-certified laboratory and its remaining assets.

Financial terms of the deal were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.